Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Insights and Forecast to 2028

Report ID: 1200991 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Product Introduction
    1.2 Market by Type
        1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Exenatied
        1.2.3 Liraglutide
        1.2.4 Lixisenatide
        1.2.5 Albiglutide
        1.2.6 Dulaglutide
    1.3 Market by Application
        1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Pharmacy
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Estimates and Forecasts 2017-2028
    2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Estimates and Forecasts 2017-2028
    2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region
        2.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2022)
        2.4.2 Global Sales Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2023-2028)
    2.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region
        2.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2022)
        2.5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Manufacturers
        3.1.1 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers by Sales (2017-2022)
        3.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists in 2021
    3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers
        3.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers (2017-2022)
        3.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2021
    3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type
        4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Sales by Type (2017-2022)
        4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Sales by Type (2023-2028)
        4.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
    4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type
        4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Revenue by Type (2017-2022)
        4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
    4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type
        4.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2017-2022)
        4.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application
        5.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Sales by Application (2017-2022)
        5.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Sales by Application (2023-2028)
        5.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
    5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application
        5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Revenue by Application (2017-2022)
        5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
    5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application
        5.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2017-2022)
        5.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
        6.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
        6.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
    6.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
        6.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
        6.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
    6.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
        6.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
        6.3.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
        7.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
        7.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
    7.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
        7.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
        7.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
    7.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
        7.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
        7.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
        8.1.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
        8.1.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
    8.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
        8.2.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
        8.2.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
    8.3 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region
        8.3.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2028)
        8.3.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
        9.1.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
        9.1.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
    9.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
        9.2.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
        9.2.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
    9.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
        9.3.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
        9.3.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
        10.1.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
    10.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
        10.2.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
    10.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
        10.3.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Corporation Information
        11.1.2 Novo Nordisk Overview
        11.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novo Nordisk Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Corporation Information
        11.2.2 AstraZeneca Overview
        11.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AstraZeneca Recent Developments
    11.3 Eli Lily
        11.3.1 Eli Lily Corporation Information
        11.3.2 Eli Lily Overview
        11.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Eli Lily Recent Developments
    11.4 GSK
        11.4.1 GSK Corporation Information
        11.4.2 GSK Overview
        11.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 GSK Recent Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Overview
        11.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanofi Recent Developments
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Corporation Information
        11.6.2 Bristol-Myers Squibb Overview
        11.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Bristol-Myers Squibb Recent Developments
    11.7 Amylin
        11.7.1 Amylin Corporation Information
        11.7.2 Amylin Overview
        11.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Amylin Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Analysis
    12.2 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Glucagon Like Peptide-1 (GLP-1) Agonists Production Mode & Process
    12.4 Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Marketing
        12.4.1 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Channels
        12.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors
    12.5 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
    13.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
    13.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
    13.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
14 Key Findings in The Global Glucagon Like Peptide-1 (GLP-1) Agonists Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Exenatied
    Table 3. Major Manufacturers of Liraglutide
    Table 4. Major Manufacturers of Lixisenatide
    Table 5. Major Manufacturers of Albiglutide
    Table 6. Major Manufacturers of Dulaglutide
    Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2022) & (K Units)
    Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2017-2022)
    Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2023-2028) & (K Units)
    Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2023-2028)
    Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2017-2022)
    Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2023-2028)
    Table 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Manufacturers (2017-2022)
    Table 19. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2017-2022)
    Table 21. Glucagon Like Peptide-1 (GLP-1) Agonists Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2021)
    Table 24. Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
    Table 26. Date of Manufacturers Enter into Glucagon Like Peptide-1 (GLP-1) Agonists Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
    Table 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
    Table 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2017-2022)
    Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2023-2028)
    Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2017-2022)
    Table 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2023-2028)
    Table 36. Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
    Table 39. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
    Table 40. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2017-2022)
    Table 41. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2023-2028)
    Table 42. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2017-2022)
    Table 45. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2023-2028)
    Table 46. Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
    Table 49. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
    Table 50. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
    Table 53. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
    Table 54. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
    Table 57. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
    Table 58. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Novo Nordisk Corporation Information
    Table 109. Novo Nordisk Description and Major Businesses
    Table 110. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Novo Nordisk Recent Developments
    Table 113. AstraZeneca Corporation Information
    Table 114. AstraZeneca Description and Major Businesses
    Table 115. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. AstraZeneca Recent Developments
    Table 118. Eli Lily Corporation Information
    Table 119. Eli Lily Description and Major Businesses
    Table 120. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Eli Lily Recent Developments
    Table 123. GSK Corporation Information
    Table 124. GSK Description and Major Businesses
    Table 125. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. GSK Recent Developments
    Table 128. Sanofi Corporation Information
    Table 129. Sanofi Description and Major Businesses
    Table 130. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Sanofi Recent Developments
    Table 133. Bristol-Myers Squibb Corporation Information
    Table 134. Bristol-Myers Squibb Description and Major Businesses
    Table 135. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Bristol-Myers Squibb Recent Developments
    Table 138. Amylin Corporation Information
    Table 139. Amylin Description and Major Businesses
    Table 140. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Amylin Recent Developments
    Table 143. Key Raw Materials Lists
    Table 144. Raw Materials Key Suppliers Lists
    Table 145. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
    Table 146. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
    Table 147. Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
    Table 148. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
    Table 149. Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
    Table 150. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
    Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type in 2021 & 2028
    Figure 3. Exenatied Product Picture
    Figure 4. Liraglutide Product Picture
    Figure 5. Lixisenatide Product Picture
    Figure 6. Albiglutide Product Picture
    Figure 7. Dulaglutide Product Picture
    Figure 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application in 2021 & 2028
    Figure 9. Hospital
    Figure 10. Pharmacy
    Figure 11. Other
    Figure 12. Glucagon Like Peptide-1 (GLP-1) Agonists Report Years Considered
    Figure 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales 2017-2028 (K Units)
    Figure 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue 2017-2028 (US$ Million)
    Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2017-2022)
    Figure 18. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2023-2028)
    Figure 19. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists in the World: Market Share by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2021
    Figure 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
    Figure 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
    Figure 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
    Figure 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
    Figure 36. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
    Figure 37. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
    Figure 38. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
    Figure 39. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
    Figure 40. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Country (2017-2028)
    Figure 41. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Country (2017-2028)
    Figure 42. U.S. Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
    Figure 45. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
    Figure 47. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Country (2017-2028)
    Figure 49. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Country (2017-2028)
    Figure 50. Germany Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 51. France Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Region (2017-2028)
    Figure 61. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 64. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Country (2017-2028)
    Figure 76. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Country (2017-2028)
    Figure 77. Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Country (2017-2028)
    Figure 86. Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2017-2028) & (US$ Million)
    Figure 89. Glucagon Like Peptide-1 (GLP-1) Agonists Value Chain
    Figure 90. Glucagon Like Peptide-1 (GLP-1) Agonists Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Frequently Asked Questions
Glucagon Like Peptide-1 (GLP-1) Agonists report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glucagon Like Peptide-1 (GLP-1) Agonists report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glucagon Like Peptide-1 (GLP-1) Agonists report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hearing Aid

Hearing Aid market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

L-Valine

L-Valine market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More

Maleic Anhydride

Maleic Anhydride market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Malic Acid

Malic Acid market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More